Log in or Sign up for Free to view tailored content for your specialty!
Retina/Vitreous News
VIDEO: Specific OCT signs associated with worsening of myopic macular schisis
ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Ramin Tadayoni, MD, PhD, speaks about myopic macular schisis and the OCT signs that can predict the worsening of this condition.
World Geographic Atrophy Day aims to empower individuals, heighten awareness
Dec. 5 is World Geographic Atrophy Day, a new initiative that seeks to empower individuals with this advanced form of dry age-related macular degeneration and expand global advocacy, education and support efforts.
Log in or Sign up for Free to view tailored content for your specialty!
Phase 2 trial of EYP-1901 in wet AMD meets all endpoints
The phase 2 DAVIO 2 trial of EYP-1901 met all primary and secondary endpoints in patients with wet age-related macular degeneration, EyePoint Pharmaceuticals announced in a press release.
Neovascular AMD treatment in ‘last push’ of development; IOL positioning system launches
Healio’s top video perspectives from Eyecelerator@AAO include a key update on sozinibercept for neovascular age-related macular degeneration and a launch announcement for the ZeptoLink IOL positioning system.
Harrow acquires NDA for Triesence
Harrow announced an early completed transfer of the new drug application for Triesence, a synthetic corticosteroid for treatment of several inflammatory ophthalmic conditions, including those not responsive to topical corticosteroids.
Positive phase 1 safety data reported for small interfering RNA technology in wet AMD
Positive safety and tolerability data were reported for OLX10212, a small interfering RNA technology, in patients with neovascular age-related macular degeneration, according to a press release from OliX Pharmaceuticals.
Food, housing insecurity among self-reported barriers to eye care
Socioeconomic and demographic factors, such as housing insecurity and mental health issues, are associated with a lower likelihood of receiving eye care, according to research published in JAMA Ophthalmology.
Pegcetacoplan safe, effective over 24 months in patients with geographic atrophy
NEW ORLEANS — Pegcetacoplan slowed lesion growth and was well-tolerated when given monthly or every other month in patients with geographic atrophy secondary to age-related macular degeneration, according to a presenter at Academy ‘23.
VIDEO: Study explores real-world treatment patterns of faricimab for wet AMD
In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Sophie J. Bakri, MD, discusses outcomes from the FARETINA-AMD study of faricimab as a treatment for age-related macular degeneration.
Standardized OCT classification, grading system needed for diabetic macular edema
Despite advances in research on OCT biomarkers of diabetic macular edema, a standardized classification and grading system is still necessary to fill knowledge gaps, according to a recently published review.